Replies to post #249903 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

Thank you.

[meirluc]

No, they’re not, “ready to manufacture 100,000 autologous vaccines a year.” (it will take years to ramp up to that level) From the latest 10-K:

I agree that it will take years to increase the manufacturing capacity from several thousand DCVax-L vaccines to over 100,00. During those years the treatment with Direct can be perfected and with money earned from the successful treatment of GBM patients with DCVax-L, the vaccine manufacturing capacity could be greatly expanded over a reasonable period of time.

Rome was not built in a day.

[flipper44]

I worry about the fact Merck (The nonGerman Merck that is) did not buy Flodesign out. It seemed like a no brainer, and Merck (nonGerman) is much more affluent. I doubt Merck will buy German Merck KGaA, but if it did, it would all make sense to me. I suppose at some point Merck is going to bounce up against monopolization regulations. Regardless, missing flodesign's very important technology seems, at first blush, to be a careless error.

Maybe I'm not that coherent this evening, so I'll cease posting until sometime in the future..

[monentum2play]

They will be able to produce 10,000 @120,000 Dcvax cost
1,200,000,000 earnings

[Hbpainter]

We believe the current manufacturing facilities have the potential to produce DCVax for at least several thousand patients per year.

If this statement is correct why go after 4 RA's concurrently when approval from one would certainly be adequate to meet current manufacturing capabilities? Is a major ramp up in progress since that statement I wonder.